The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis and uterine fibroids , as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. Works cross-functionally with field sales leadership, specifically Regional Sales Managers (RSM), Account Specialists, national account directors (NAD), network pharmacy, and home office colleagues within market access and other related functional departments, such as commercial analytics and operations, to support patient access with specific payers.